FDA approves First blood Test to Identify fatal allergy to Red Meat

Written By :  Dr. Kamal Kant Kohli
Published On 2020-07-24 03:32 GMT   |   Update On 2020-07-24 09:14 GMT

PORTAGE --The U.S. Food & Drug Administration (FDA) has approved ImmunoCAP Specific IgE alpha-Gal Allergen Component test to help specialists and other healthcare providers Identify Allergic Sensitization to Red Meat. The test helps diagnose a patient's sensitization to the alpha-Gal carbohydrate found in red meat and assess his or her risk for an anaphylactic reaction.Food and...

Login or Register to read the full article

PORTAGE --The U.S. Food & Drug Administration (FDA) has approved ImmunoCAP Specific IgE alpha-Gal Allergen Component test to help specialists and other healthcare providers Identify Allergic Sensitization to Red Meat.

The test helps diagnose a patient's sensitization to the alpha-Gal carbohydrate found in red meat and assess his or her risk for an anaphylactic reaction.

Food and drug administration has granted approval to Thermo Fisher Scientific for ImmunoCAP Specific IgE alpha-Gal Allergen Component test to help clinicians pinpoint a potentially fatal allergy often resulting from tick bites.

ImmunoCAP Specific IgE blood testing is the most widely used specific IgE blood test, and its use is documented in more than 6,000 peer-reviewed publications. The tests can help identify allergic sensitization to common environmental allergens – seasonal and perennial, outdoor and indoor– as well as common food allergens such as peanut, egg and milk.

Sensitization to the alpha-Gal carbohydrate has been notoriously difficult to measure in patients," said Dr. Lakiea Wright, MD MAT MPH, Medical Director, US ImmunoDiagnostics at Thermo Fisher Scientific. "Skin prick testing to red meats such as beef, pork, or lamb often gives weak or negative results, which is why, based on clinical studies, quantification of IgE antibodies to alpha-Gal in the blood is the preferred diagnostic method. Information from these tests can help providers be more precise in their diagnosis and management recommendations."

According to the American Academy of Asthma, Allergy and Immunology, an allergy to alpha-Gal can cause patients to have a severe and potentially life-threatening reaction to galactose-alpha-1, 3-galactose that is found in most mammalian (red) meat. Unlike other food allergies, reactions from eating red meat may be delayed, occurring three to eight hours after eating. Symptoms range from hives and itching, to abdominal pain, nausea or vomiting. In severe cases the allergy can cause anaphylaxis which can be potentially fatal. The condition can appear in patients who have tolerated meat for many years, with researchers believing that sensitization to alpha-Gal may be the result of a bite from the lone star tick (Amblyomma americanum).

"Alpha-gal is dramatically different from other forms of food allergy," said Thomas Platts-Mills, MD, professor of medicine and microbiology at the University of Virginia School of Medicine and a leading researcher on the topic. "Previously healthy adults can suddenly develop potentially life-threatening reactions to red meats such as beef, pork and lamb. The delayed nature of the reactions adds to the difficulty that clinicians and patients have in identifying the cause of the symptoms. This unique set of circumstances makes an accurate diagnosis critical for managing this disease."

The ImmunoCAP Specific IgE Stinging Insect Allergen Component tests were recently cleared by the Food & Drug Administration to help improve the diagnosis of bee and wasp allergies. ImmunoCAP Specific IgE blood tests, which are available in most major U.S. laboratories, can be ordered for patients of any age regardless of skin condition, current medication, disease activity or pregnancy status.

For further information, please visit www.thermofisher.com.

Tags:    
Article Source : FDA

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News